A clinical, cytologic and histologic study of 14 cases. In-situ and microinvasive adenocarcinoma of the uterine cervix. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions I. Expanded cytologic criteria for the diagnosis of adenocarcinoma in situ of the cervix and related lesions. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri. Krumins I, Young Q, Pacey F, Bousfield L, Mulhearn L. Adenocarcinoma in situ of the endocervix. WHO classification of tumours of female reproductive organs. Kurman RJ, Carcangiu M-L, Herrington CS, Young RH. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. 2011 128(4):927–35.ĭe Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix. Tornesello ML, Losito S, Benincasa G, Fulciniti F, Botti G, Greggi S, et al. Members of the human papillomavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study. Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States). Lacey Jr JV, Frisch M, Brinton LA, Abbas FM, Barnes WA, Gravitt PE, et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, et al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. 2000 77(1):149–54.Īppleby P, Beral V, Berrington de Gonzalez A, Colin D, Franceschi S, Goodill A, et al. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Lacey Jr JV, Brinton LA, Barnes WA, Gravitt PE, Greenberg MD, Hadjimichael OC, et al. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Lacey Jr JV, Brinton LA, Abbas FM, Barnes WA, Gravitt PE, Greenberg MD, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. 2000 157(4):1055–62.Ĭastellsague X, Diaz M, de Sanjose S, Munoz N, Herrero R, Franceschi S, et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Pirog EC, Kleter B, Olgac S, Bobkiewicz P, Lindeman J, Quint WG, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. 2012 126(3):330–3.īray F, Carstensen B, Moller H, Zappa M, Zakelj MP, Lawrence G, et al. Changing demographics of cervical cancer in the United States (1973–2008). Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez EA, Plaxe SC. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000. Wang SS, Sherman ME, Hildesheim A, Lacey Jr JV, Devesa S. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States – a 24-year population-based study. Cervical cancer in the Netherlands 1989–1998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Adenocarcinoma and adenosquamous cell carcinomas. International trends in the incidence of cervical cancer: I. Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, Parkin DM.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |